About this ETF
The iShares U.S. Healthcare ETF is designed to mirror the investment performance of a benchmark index that consists of stocks from American companies within the healthcare industry.
Description from the fund data provider · profile as of Aug 27, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | +6.81% | +17.25% | +11.31% | +12.75% | +27.12% | +9.33% | +4.72% | +9.25% | +9.05% |
| Total return | +6.81% | +17.55% | +11.94% | +13.38% | +28.75% | +10.70% | +5.97% | +10.64% | +10.54% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Aug 26, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.38% | Annual cost of a $10,000 investment | $38.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Aug 26, 2026 — portfolio reporting date from the data provider; holdings are not live positions. 103 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | ELI LILLY | LLY | 14.97% | 475.80K | $587.0M |
| 2 | JOHNSON & JOHNSON | JNJ | 10.00% | 1.44M | $392.2M |
| 3 | ABBVIE | ABBV | 7.15% | 1.06M | $280.4M |
| 4 | MERCK & CO INC | MRK | 5.88% | 1.47M | $230.7M |
| 5 | UNITEDHEALTH GROUP INC | UNH | 5.44% | 538.14K | $213.4M |
| 6 | AMGEN INC | AMGN | 3.63% | 321.67K | $142.3M |
| 7 | THERMO FISHER SCIENTIFIC INC | TMO | 3.55% | 221.56K | $139.2M |
| 8 | ABBOTT LABORATORIES | ABT | 3.06% | 1.03M | $119.9M |
| 9 | GILEAD SCIENCES | GILD | 2.81% | 740.37K | $110.1M |
| 10 | PFIZER | PFE | 2.47% | 3.39M | $96.9M |
| 11 | VERTEX PHARMACEUTICALS | VRTX | 2.14% | 151.51K | $83.8M |
| 12 | BRISTOL MYERS SQUIBB | BMY | 2.11% | 1.22M | $82.7M |
| 13 | DANAHER | DHR | 2.07% | 376.60K | $81.3M |
| 14 | INTUITIVE SURGICAL INC | ISRG | 1.99% | 210.09K | $78.1M |
| 15 | MEDTRONIC PLC | 0Y6X.L | 1.78% | 764.42K | $69.7M |
| 16 | STRYKER | SYK | 1.74% | 206.10K | $68.1M |
| 17 | ELEVANCE HEALTH INC | ANTM | 1.32% | 129.38K | $51.6M |
| 18 | REGENERON PHARMACEUTICALS | REGN | 1.28% | 60.24K | $50.2M |
| 19 | BOSTON SCIENTIFIC CORP | BSX | 1.12% | 883.67K | $44.1M |
| 20 | CIGNA | CI | 1.11% | 155.61K | $43.5M |
| 21 | HCA HEALTHCARE | HCA | 0.97% | 89.00K | $38.2M |
| 22 | MODERNA INC | MRNA | 0.88% | 217.25K | $34.5M |
| 23 | BECTON DICKINSON | BDXA | 0.82% | 169.44K | $32.2M |
| 24 | EDWARDS LIFESCIENCES | EW | 0.79% | 339.76K | $30.9M |
| 25 | HUMANA | HUM | 0.71% | 71.54K | $27.9M |
Click a ticker to see every ETF that owns it.
Sector Exposure
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | 1.09% | Paid (last 12 months) | $0.8007 |
| Frequency | Quarterly | SEC yield | Not provided by our data source — see the issuer page |
| Last ex-date | Jun 15, 2026 | Last payment | $0.1634 (Jun 18, 2026) |
| Growth 1Y | +4.76% | Growth 3Y / 5Y (ann.) | -36.68% / -22.35% |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Jun 15, 2026 | Jun 15, 2026 | Jun 18, 2026 | $0.1634 |
| Mar 17, 2026 | Mar 17, 2026 | Mar 20, 2026 | $0.1948 |
| Dec 16, 2025 | Dec 16, 2025 | Dec 19, 2025 | $0.2497 |
| Sep 16, 2025 | Sep 16, 2025 | Sep 19, 2025 | $0.1928 |
| Jun 16, 2025 | Jun 16, 2025 | Jun 20, 2025 | $0.1682 |
| Mar 18, 2025 | Mar 18, 2025 | Mar 21, 2025 | $0.1624 |
| Dec 17, 2024 | Dec 17, 2024 | Dec 20, 2024 | $0.1995 |
| Sep 25, 2024 | Sep 25, 2024 | Sep 30, 2024 | $0.2342 |
| Jun 11, 2024 | Jun 11, 2024 | Jun 17, 2024 | $0.1258 |
| Mar 21, 2024 | Mar 22, 2024 | Mar 27, 2024 | $0.1666 |
| Dec 20, 2023 | Dec 21, 2023 | Dec 27, 2023 | $0.8888 |
| Sep 26, 2023 | Sep 27, 2023 | Oct 02, 2023 | $1.1702 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
| Volatility 1Y / 3Y | 16.00% / 14.85% | Sharpe 1Y / 3Y | 1.68 / 0.558 |
| Max drawdown 1Y / 3Y | -10.65% / -17.91% | Sortino 1Y | 2.89 |
| Beta vs S&P 500 (3Y) | 0.481 | Correlation vs S&P 500 (1Y) | 0.257 |
| Downside deviation 1Y | 9.28% | Risk-free rate used | 3.71% (3M T-bill, FRED) |
Computed by ETF Explorer from daily dividend-adjusted closes; volatility and drawdown are annualized/period figures; S&P 500 exposure proxied by SPY. As of Aug 27, 2026. Formulas →
Liquidity
| Volume today | 331.77K | Average volume | 755.57K |
| AUM | $3.93B | Premium/Discount | -0.98% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV — an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Day | $0.00 | 0.00% | $3.93B → $3.93B |
| 1 Week | $155.9M | +4.16% | $3.75B → $3.93B |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source — review them before investing.
Latest News for IYH
No articles mention this fund directly in the last 7 days — showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.
IYH